ArticleCancers2021

Actionable Molecular Alterations Are Revealed in Majority of Advanced Non-Small Cell Lung Cancer Patients by Genomic Tumor Profiling at Progression after First Line Treatment.

Malene Støchkel Frank et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.